DOI QR코드

DOI QR Code

Fibroblasts 세포주의 세포골격에서 아르곤 플라즈마의 효과: Cancer Therapy의 새로운 접근방법

Effects of Argon-plasma Jet on the Cytoskeleton of Fibroblasts: Implications of a New Approach for Cancer Therapy

  • 한지혜 (가톨릭대학교 의생명과학교실) ;
  • 남민경 (가톨릭대학교 의생명과학교실) ;
  • 김용희 (광운대학교 플라즈마 바이오과학 연구센터) ;
  • 박대욱 (가톨릭대학교 의생명과학교실) ;
  • 최은하 (광운대학교 플라즈마 바이오과학 연구센터) ;
  • 임향숙 (가톨릭대학교 의생명과학교실)
  • Han, Ji-Hye (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) ;
  • Nam, Min-Kyung (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) ;
  • Kim, Yong-Hee (Plasma Bioscience Research Center, Kwangwoon University) ;
  • Park, Dae-Wook (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) ;
  • Choi, Eun Ha (Plasma Bioscience Research Center, Kwangwoon University) ;
  • Rhim, Hyangshuk (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea)
  • 투고 : 2012.09.28
  • 심사 : 2012.10.11
  • 발행 : 2012.10.31

초록

Argon-plasma jet (Ar-PJ) is generated by ionizing Ar gas, and the resulting Ar-PJ consists of a mixture of neutral particles, positive ions, negative electrons, and various reactive species. Although Ar-PJ has been used in various biomedical applications, little is known about the biological effects on cells located near the plasma-exposed region. Here, we investigated the effects of the Ar-PJ on actin cytoskeleton of mouse embryonic fibroblasts (MEFs) in response to indirect as well as direct exposure to Ar-PJ. This Ar-PJ was generated at 500 mL/min of flow rate and 100 V electric power by our device mainly consisting of electrodes, dielectrics, and a high-voltage power supply. Because actin cytoskeleton is the key cellular machinery involved in cellular movement and is implicated in regulation of cancer metastasis and thus resulting in a highly desirable cancer therapeutic target, we examined the actin filament architectures in Ar-PJ-treated MEFs by staining with an actin-specific phalloidin labeled with fluorescent dye. Interestingly, the Ar-PJ treatment causes destabilization of actin filament architectures in the regions indirectly exposed to Ar-PJ, but no differences in MEFs treated with Ar gas alone and in untreated cell control, indicating that this phenomenon is a specific cellular response against Ar-PJ in the live cells, which are indirectly exposed to Ar-PJ. Collectively, our study raises the possibility that Ar-PJ may have potential as anti-cancer drug effect through direct destabilization of the actin cytoskeleton.

키워드

참고문헌

  1. Kim, S. H., J. H. Kim, B. K. Kang, and H. S. Uhm (2005) Superhydrophobic CFx coating via in-line atmospheric RF plasma of He-CF4-H2. Langmuir. 21: 12213-12217. https://doi.org/10.1021/la0521948
  2. Kilmer, S., N. Semchyshyn, G. Shah, and R. Fitzpatrick (2007) A pilot study on the use of a plasma skin regeneration device (Portrait PSR3) in full facial rejuvenation procedures. Lasers Med. Sci. 22: 101-109. https://doi.org/10.1007/s10103-006-0431-9
  3. Potter, M. J., et al. (2007) Facial acne and fine lines: transforming patient outcomes with plasma skin regeneration. Ann. Plast Surg. 58: 608-613. https://doi.org/10.1097/01.sap.0000252481.84134.fe
  4. Bogle, M. A., K. A. Arndt, and J. S. Dover (2007) Evaluation of plasma skin regeneration technology in low-energy full-facial rejuvenation. Arch. Dermatol. 143: 168-174. https://doi.org/10.1001/archderm.143.2.168
  5. Grund, K. E., D. Storek, and G. Farin (1994) Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc. Surg. Allied Technol. 2: 42-46.
  6. Klein, C. A. (2008) Cancer. The metastasis cascade. Science 321: 1785-1787. https://doi.org/10.1126/science.1164853
  7. Chiang, A. C. and J. Massague (2008) Molecular basis of metastasis. N. Engl. J. Med. 359: 2814-2823. https://doi.org/10.1056/NEJMra0805239
  8. Kedrin, D., J. van Rheenen, L. Hernandez, J. Condeelis, and J. E. Segall (2007) Cell motility and cytoskeletal regulation in invasion and metastasis. J. Mammary Gland Biol. Neoplasia 12: 143-152. https://doi.org/10.1007/s10911-007-9046-4
  9. Rhodes, L. V., et al. (2011) Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res. 71: 603-613. https://doi.org/10.1158/0008-5472.CAN-10-3185
  10. Entschladen, F., Drell, T. L. t., Lang, K., Joseph, J., and Zaenker, K. S. (2004) Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 5: 254-258. https://doi.org/10.1016/S1470-2045(04)01431-7
  11. Olson, M. F. and E. Sahai (2009) The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26: 273-287. https://doi.org/10.1007/s10585-008-9174-2
  12. Nobes, C. D. and A. Hall (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81: 53-62. https://doi.org/10.1016/0092-8674(95)90370-4
  13. Wennerberg, K. and C. J. Der (2004) Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117: 1301-1312. https://doi.org/10.1242/jcs.01118
  14. Fritz, G., C. Brachetti, F. Bahlmann, M. Schmidt, and B. Kaina (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87: 635-644. https://doi.org/10.1038/sj.bjc.6600510
  15. Frixione, E. (2000) Recurring views on the structure and function of the cytoskeleton: a 300-year epic. Cell Motil Cytoskeleton 46: 73-94. https://doi.org/10.1002/1097-0169(200006)46:2<73::AID-CM1>3.0.CO;2-0
  16. Doherty, G. J. and H. T. McMahon (2008) Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu. Rev. Biophys. 37: 65-95. https://doi.org/10.1146/annurev.biophys.37.032807.125912
  17. Fuchs, E. and D. W. Cleveland (1998) A structural scaffolding of intermediate filaments in health and disease. Science 279: 514-519. https://doi.org/10.1126/science.279.5350.514
  18. Suresh, S. (2007) Biomechanics and biophysics of cancer cells. Acta Biomater 3: 413-438. https://doi.org/10.1016/j.actbio.2007.04.002
  19. Jordan, M. A. and Wilson, L. (1998) Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol. 10: 123-130. https://doi.org/10.1016/S0955-0674(98)80095-1
  20. Sharma, S., et al. (2012) Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells. Nanomedicine 8: 757-766. https://doi.org/10.1016/j.nano.2011.09.015
  21. Statsuk, A. V., et al. (2005) Actin is the primary cellular receptor of bistramide A. Nat. Chem Biol. 1: 383-388. https://doi.org/10.1038/nchembio748
  22. Hayot, C., et al. (2006) Characterization of the activities of actinaffecting drugs on tumor cell migration. Toxicol Appl Pharmacol. 211: 30-40. https://doi.org/10.1016/j.taap.2005.06.006
  23. Coue, M., S. L. Brenner, I. Spector, and E. D. Korn (1987) Inhibition of actin polymerization by latrunculin A. FEBS Lett. 213: 316-318. https://doi.org/10.1016/0014-5793(87)81513-2
  24. Hemstreet, G. P., 3rd, et al. (1996) G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J. Cell Biochem. Suppl. 25: 197-204.
  25. Baskar, R., K. A. Lee, R. Yeo, and K. W. Yeoh (2012) Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9: 193-199. https://doi.org/10.7150/ijms.3635
  26. DeVita, V. T., Jr. and E. Chu (2008) A history of cancer chemotherapy. Cancer Res. 68: 8643-8653. https://doi.org/10.1158/0008-5472.CAN-07-6611

피인용 문헌

  1. Effects of DBD-bio-plasma on the HSP70 of Fibroblasts: A New Approach on Change of Molecular Level by Heat Shock in the Cell vol.30, pp.1, 2015, https://doi.org/10.7841/ksbbj.2015.30.1.21
  2. Harmless effects of argon plasma on caudal fin regeneration and embryogenesis of zebrafish: novel biological approaches for safe medical applications of bioplasma vol.49, pp.7, 2017, https://doi.org/10.1038/emm.2017.95